Convidado


PIETRO LAPADARI

PIETRO LAPADARI

FRANCE

A Medical Oncologist and PhD student at Gustave Roussy (Villejuif, France) in the Breast
Cancer Survivorship Research Group (led by Dr Vaz-Luis). I have the privilege to be involved in
one of the largest contemporary clinical studies in Breast Cancer survivorship, the CANcer
TOxicity study (CANTO). I mainly focused on characterizing treatment-related toxicity, with a
spotlight on aromatase inhibitor musculoskeletal toxicity, and on after cancer pathways.

Imprimir Conflito de interesse

Atividades

Voltar